Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Expert Opinion on Investigational Drugs
|
January 22, 2026
A randomized, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics and ammonia-lowering effect of Rifaquizinone, an intestinally restricted investigational drug
Mengdi Lu, Jing Chen, Hong Zhang, et al.
ACS Sensors
|
February 11, 2026
Integration of Dual Functions of Cytosensing and Highly Efficient Photothermal Therapy Using a Cascaded Ω-Shaped Fiber Optic Localized Surface Plasmon Resonance Sensor
Kun Xu, Xiaotao Ning, Yang Yang, et al.
NPJ Precision Oncology
|
April 16, 2025
Integrating bulk, single-cell, and spatial transcriptomics to identify and functionally validate novel targets to enhance immunotherapy in NSCLC
Kui Cao, Shenshui Wei, Tianjiao Ma, et al.
Journal of Nanobiotechnology
|
February 26, 2024
Highly sensitive SERS platform for pathogen analysis by cyclic DNA nanostructure@AuNP tags and cascade primer exchange reaction
Yunju Xiao, Shihua Luo, Jiuxiang Qiu, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 18, 2026
Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children ≥2 years with cystic fibrosis: 96-week interim results from a phase 3 open-label extension study
Jennifer L Goralski, Cori Daines, Jessica E Pittman, et al.
BMJ Open Respiratory Research
|
November 6, 2021
Effect modification by age of the association between obstructive lung diseases, smoking, and COVID-19 severity
Peter P Moschovis, Mengdi Lu, Douglas Hayden, et al.
The American Journal of Clinical Nutrition
|
April 19, 2023
The Impact of Baseline 25-Hydroxyvitamin D Level and Gestational Age on Prenatal Vitamin D Supplementation to Prevent Offspring Asthma or Recurrent Wheezing
Iskander Lc Shadid, Nicklas Brustad, Mengdi Lu, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 8, 2023
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ⩾6 Years with Cystic Fibrosis and at Least One <i>F508del</i> Allele: A Phase 3, Open-Label Clinical Trial
Claire Wainwright, Susanna A McColley, Paul McNally, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 24, 2021
The Association of Prenatal Vitamin D Sufficiency With Aeroallergen Sensitization and Allergic Rhinitis in Early Childhood
Yih-Chieh S Chen, Hooman Mirzakhani, Mengdi Lu, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 15, 2023
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One <i>F508del</i> Allele
Jennifer L Goralski, Jordana E Hoppe, Marcus A Mall, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Expert Opinion on Investigational Drugs
|
January 22, 2026
A randomized, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics and ammonia-lowering effect of Rifaquizinone, an intestinally restricted investigational drug
Mengdi Lu, Jing Chen, Hong Zhang, et al.
ACS Sensors
|
February 11, 2026
Integration of Dual Functions of Cytosensing and Highly Efficient Photothermal Therapy Using a Cascaded Ω-Shaped Fiber Optic Localized Surface Plasmon Resonance Sensor
Kun Xu, Xiaotao Ning, Yang Yang, et al.
NPJ Precision Oncology
|
April 16, 2025
Integrating bulk, single-cell, and spatial transcriptomics to identify and functionally validate novel targets to enhance immunotherapy in NSCLC
Kui Cao, Shenshui Wei, Tianjiao Ma, et al.
Journal of Nanobiotechnology
|
February 26, 2024
Highly sensitive SERS platform for pathogen analysis by cyclic DNA nanostructure@AuNP tags and cascade primer exchange reaction
Yunju Xiao, Shihua Luo, Jiuxiang Qiu, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 18, 2026
Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children ≥2 years with cystic fibrosis: 96-week interim results from a phase 3 open-label extension study
Jennifer L Goralski, Cori Daines, Jessica E Pittman, et al.
BMJ Open Respiratory Research
|
November 6, 2021
Effect modification by age of the association between obstructive lung diseases, smoking, and COVID-19 severity
Peter P Moschovis, Mengdi Lu, Douglas Hayden, et al.
The American Journal of Clinical Nutrition
|
April 19, 2023
The Impact of Baseline 25-Hydroxyvitamin D Level and Gestational Age on Prenatal Vitamin D Supplementation to Prevent Offspring Asthma or Recurrent Wheezing
Iskander Lc Shadid, Nicklas Brustad, Mengdi Lu, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 8, 2023
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ⩾6 Years with Cystic Fibrosis and at Least One <i>F508del</i> Allele: A Phase 3, Open-Label Clinical Trial
Claire Wainwright, Susanna A McColley, Paul McNally, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 24, 2021
The Association of Prenatal Vitamin D Sufficiency With Aeroallergen Sensitization and Allergic Rhinitis in Early Childhood
Yih-Chieh S Chen, Hooman Mirzakhani, Mengdi Lu, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 15, 2023
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One <i>F508del</i> Allele
Jennifer L Goralski, Jordana E Hoppe, Marcus A Mall, et al.
Page
of 5